P2RY11 IDG GPCR ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with P2RY11 IDG GPCR ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with P2RY11 IDG GPCR ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with P2RY11 IDG GPCR ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with P2RY11 IDG GPCR ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

GTP binding protein 6

Gene

ribosomal protein lateral stalk subunit P0 pseudogene 2

Gene

ribosomal protein L32 pseudogene 3

Gene

ribosomal protein L5 pseudogene 29

Gene

NACA family member 4, pseudogene

Gene

MT-ND2 pseudogene 12

Gene

general transcription factor IIi pseudogene 11

Gene

SMARCE1 pseudogene 2

Gene

PPP1R2 family member B

  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    GTP binding protein 6


  • Gene

    ribosomal protein lateral stalk subunit P0 pseudogene 2


  • Gene

    ribosomal protein L32 pseudogene 3


  • Gene

    ribosomal protein L5 pseudogene 29


  • Gene

    NACA family member 4, pseudogene


  • Gene

    MT-ND2 pseudogene 12


  • Gene

    general transcription factor IIi pseudogene 11


  • Gene

    SMARCE1 pseudogene 2


  • Gene

    PPP1R2 family member B

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.